A

Angiocrine Bioscience, Inc.

32 employees

Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.

Basic info

biotechnology research

Biotechnology

Health Diagnostics

Health Care

Proprietary genetically engineered cellular E-CEL™ Technology Platform

Therapeutics

cellular regenerative medicine

hematopoietic stem cell gene therapy.

with potential applications in cellular immunotherapy for hematologic cancers

2012